Formerly known as NAFLD/NASH, metabolic dysfunction-associated steatotic liver disease (MASLD) involves fat buildup in the liver. When inflammation and damage occur, it progresses to MASH, raising the risk of fibrosis and complications.
MASH occurs when excess liver fat triggers inflammation, leading to injury of liver cells, fibrosis, and potential cirrhosis, disrupting normal liver function and increasing the risk of liver cancer.
MASH is a progressive disease that can lead to irreversible cirrhosis if untreated, but early intervention including diet, exercise, and medication can help slow or even reverse fibrosis. Don’t wait—ask your specialist about treatment options to protect your liver health.
MASH affects an estimated 5.27% of the global population.
People with obesity or type 2 diabetes face a higher risk of metabolic dysfunction-associated steatotic liver disease (MASLD), which affects an over 30% of people worldwide. Approximately 20% of MASLD cases advance to MASH.
Taking a proactive approach to managing MASH is essential to slowing disease progression and protecting liver health.
Moderate exercise such as brisk walking, cycling, or swimming, can help reduce liver fat and improve overall metabolic health.
Focus on lean protein, whole grains, healthy fats, and fiber-rich foods, while limiting sugar, refined carbs, and processed fats to reduce liver stress.
Losing just 5-10% of body weight can significantly reduce fat and inflammation in the liver, slowing disease progression.
Connect with family, friends, or support groups to stay motivated, manage stress, and maintain healthy lifestyle changes for better long-term MASH management.
MASH can progress without symptoms, so routine liver function tests, imaging, and specialist visits are critical.